Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-05 · 43 (5) · 618-627
DOI: 10.1161/atvbaha.123.316246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-05. Verfasst von Bradley Tucker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia (B.T., J.E.). Hauptthemen laut MEDLINE: Neutrophils, Atherosclerosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Atherosclerosis is complex chronic disease characterized by intimal cholesterol accumulation and vascular inflammation. There is a well-established relationship of hypercholesterolemia and inflammation with atherosclerosis. However, the link between inflammation and cholesterol is not completely understood. Myeloid cells, in particular, monocytes, macrophages, and neutrophils play essential roles in the pathogenesis of atherosclerotic cardiovascular disease. It is well known that macrophages accumulate cholesterol, forming foam cells, which drive atherosclerosis-associated inflammation. However, the interaction between cholesterol and neutrophils remains poorly defined—an important gap in the literature given that neutrophils represent up to 70% of total circulating leukocytes in humans. Elevated levels of biomarkers of neutrophil activation (myeloperoxidase and neutrophil extracellular traps) and higher absolute neutrophil counts are both associated with increased rates of cardiovascular events. Neutrophils contain the necessary machinery to uptake, synthesize, efflux and esterify cholesterol; yet, the functional consequence of dysregulated cholesterol homeostasis on neutrophil activity remains poorly defined. Preclinical animal data suggest a direct link between cholesterol metabolism and hematopoiesis, although current evidence in humans has been unable to corroborate such findings. This review will explore the impact of impaired cholesterol homeostasis neutrophils and draw focus on the discordant data from animal models and atherosclerotic disease in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sydney Medical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia (B.T., J.E.).
- Royal Prince Alfred Hospital, Camperdown, NSW, Australia (B.T., J.E.).
- School of Biomedical Sciences, Faculty of Medicine & Health, UNSW Sydney, NSW, Australia (T.W.K., K.A., K.-A.R., B.J.C.).
ORCID-Profile: Bradley Tucker, Kerry-Anne Rye, Blake J Cochran
Zitieren
APA
Tucker, B., Ephraums, J., King, T. W., Abburi, K., Rye, K. A., & Cochran, B. J. (2023). Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(5), 618-627. https://doi.org/10.1161/atvbaha.123.316246
Vancouver
Tucker B, Ephraums J, King TW, Abburi K, Rye KA, Cochran BJ. Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(5):618-627. doi:10.1161/atvbaha.123.316246
BibTeX
@article{Tucker2023,
author = {Tucker, Bradley and Ephraums, James and King, Thomas W and Abburi, Kaivalya and Rye, Kerry-Anne and Cochran, Blake J},
title = {Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {5},
pages = {618--627},
doi = {10.1161/atvbaha.123.316246}
}
EUVIMED